The China bioprocess instruments market size was estimated at USD 1.18 billion in 2016 and is expected to grow on account of the evolution of new technologies. An ageing population and increasing occurrences of lifestyle related illnesses among youth are expected to augment the growth of the healthcare sector in the country over the next few years.
The government of China has been focusing on biopharmaceuticals and is undertaking initiatives to enhance pharmaceutical innovation to pursue its goal of becoming an emerging biosimilar development hub.
Details
- Publication Date
- Apr 30, 2018
- Language
- English
- Category
- Science & Medicine
- Copyright
- All Rights Reserved - Standard Copyright License
- Contributors
- By (author): susan hill
Specifications
- Format